IRVINE, Calif., Aug. 23, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that veteran sales and diagnostic executive Mark McDonough has been named Chief Commercial Officer, effective immediately. McDonough, 43, will report directly to CombiMatrix CEO R. Judd Jessup.
